The Mechanism and Clinical Application of Transcutaneous Electrical Nerve Stimulation in The Treatment of Neuropathological Pain after Spinal Cord Injury
DOI:
https://doi.org/10.70088/8drh6c73Keywords:
neuromodulation, spinal cord injury, neuropathic pain, electrical stimulation, pain management, analgesiaAbstract
Transcutaneous electrical nerve stimulation (TENS), functioning as a prominent non-invasive neuromodulation technique, has been widely utilized as a critical adjuvant treatment for managing neuropathic pain (NP) following spinal cord injury (SCI). This article systematically reviews the underlying physiological mechanisms of TENS in alleviating NP after SCI, alongside its recent clinical application progress. Extensive studies have demonstrated that the profound analgesic effect of TENS may be intricately linked to the activation of thick myelinated Aβ fibers, which subsequently enhances the segmental inhibition of the spinal cord. Furthermore, TENS is implicated in promoting the release of endogenous opioids, regulating the descending pain inhibition pathways, significantly reducing central sensitization, and modulating complex neuroimmune responses within the central nervous system. In terms of clinical application, empirical evidence indicates that both high-frequency and low-frequency TENS modalities can substantially reduce the intensity of NP after SCI, thereby markedly improving the overall quality of life for affected patients. Despite these promising outcomes, notable individual differences in therapeutic efficacy persist, and the optimal stimulation parameters and standardized intervention protocols have yet to be universally established. The existing body of evidence firmly supports TENS as a safe, accessible, and highly effective non-pharmacological option for treating NP after SCI. Nevertheless, comprehensive, large-sample, high-quality, and long-term follow-up clinical trials are still urgently required to further optimize targeted treatment strategies and to fully elucidate the underlying neuroplasticity mechanisms driving long-term pain relief.References
E. Widerström-Noga, "Neuropathic Pain and Spinal Cord Injury: Management, Phenotypes, and Biomarkers," pain, vol. 7, no. 9, p. 10, 2023.
S. T. Lubejko, R. D. Graham, G. Livrizzi, R. Schaefer, M. R. Banghart, and M. C. Creed, "The role of endogenous opioid neuropeptides in neurostimulation-driven analgesia," Frontiers in Systems Neuroscience, vol. 16, p. 1044686, 2022.
A. D. Kaye, G. Armistead, L. S. Amedio, M. E. Manthei, S. Ahmadzadeh, B. Bernhardt, and S. Shekoohi, "Evolving treatment strategies for neuropathic pain: a narrative review," Medicina, vol. 61, no. 6, p. 1063, 2025.
E. G. Widerström-Noga and D. C. Turk, "Types and effectiveness of treatments used by people with chronic pain associated with spinal cord injuries: influence of pain and psychosocial characteristics," Spinal Cord, vol. 41, no. 11, pp. 600–609, 2003.
A. D. Sdrulla, Y. Guan, and S. N. Raja, "Spinal cord stimulation: clinical efficacy and potential mechanisms," Pain Practice, vol. 18, no. 8, pp. 1048–1067, 2018.
R. Melzack and P. D. Wall, "Pain Mechanisms: A New Theory: A gate control system modulates sensory input from the skin before it evokes pain perception and response," Science, vol. 150, no. 3699, pp. 971–979, 1965.
M. I. Johnson and J. M. Bjordal, "Transcutaneous electrical nerve stimulation for the management of painful conditions: focus on neuropathic pain," Expert Review of Neurotherapeutics, vol. 11, no. 5, pp. 735–753, 2011.
R. Shiao and C. A. Lee-Kubli, "Neuropathic pain after spinal cord injury: challenges and research perspectives," Neurotherapeutics, vol. 15, no. 3, pp. 635–653, 2018.
P. Boadas-Vaello, S. Castany, J. Homs, B. Álvarez-Pérez, M. Deulofeu, and E. Verdú, "Neuroplasticity of ascending and descending pathways after somatosensory system injury: reviewing knowledge to identify neuropathic pain therapeutic targets," Spinal Cord, vol. 54, no. 5, pp. 330–340, 2016.
M. Johnson, "Transcutaneous electrical nerve stimulation: mechanisms, clinical application and evidence," Reviews in Pain, vol. 1, no. 1, pp. 7–11, 2007.
K. A. Sluka, M. A. Judge, M. M. McColley, and P. M. Reveiz, "Low frequency TENS is less effective than high frequency TENS at reducing inflammation-induced hyperalgesia in morphine-tolerant rats," European Journal of Pain, vol. 4, no. 2, pp. 185–193, 2000.
R. Ahmadi, R. Kuner, N. Weidner, J. Keßler, M. Bendszus, and S. M. Krieg, "The diagnosis and treatment of neuropathic pain," Deutsches Ärzteblatt International, vol. 121, no. 25, p. 825, 2024.
K. A. Sluka, C. G. T. Vance, and T. L. Lisi, "High‐frequency, but not low‐frequency, transcutaneous electrical nerve stimulation reduces aspartate and glutamate release in the spinal cord dorsal horn," Journal of Neurochemistry, vol. 95, no. 6, pp. 1794–1801, 2005.
M. H. Ossipov, K. Morimura, and F. Porreca, "Descending pain modulation and chronification of pain," Current Opinion in Supportive and Palliative Care, vol. 8, no. 2, pp. 143–151, 2014.
C. G. Vance, D. L. Dailey, R. L. Chimenti, B. J. Van Gorp, L. J. Crofford, and K. A. Sluka, "Using TENS for pain control: update on the state of the evidence," Medicina, vol. 58, no. 10, p. 1332, 2022.
A. Latremoliere and C. J. Woolf, "Central sensitization: a generator of pain hypersensitivity by central neural plasticity," The Journal of Pain, vol. 10, no. 9, pp. 895–926, 2009.
J. M. DeSantana, D. M. Walsh, C. Vance, B. A. Rakel, and K. A. Sluka, "Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain," Current Rheumatology Reports, vol. 10, no. 6, pp. 492–499, 2008.
C. E. Hulsebosch, B. C. Hains, E. D. Crown, and S. M. Carlton, "Mechanisms of chronic central neuropathic pain after spinal cord injury," Brain Research Reviews, vol. 60, no. 1, pp. 202–213, 2009.
P. K. Eide, "Pathophysiological mechanisms of central neuropathic pain after spinal cord injury," Spinal Cord, vol. 36, no. 9, pp. 601–612, 1998.
Y. T. Ma and K. A. Sluka, "Reduction in inflammation-induced sensitization of dorsal horn neurons by transcutaneous electrical nerve stimulation in anesthetized rats," Experimental Brain Research, vol. 137, no. 1, pp. 94–102, 2001.
R. Radhakrishnan, E. W. King, J. K. Dickman, C. A. Herold, N. F. Johnston, M. L. Spurgin, and K. A. Sluka, "Spinal 5-HT2 and 5-HT3 receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats," Pain, vol. 105, no. 1–2, pp. 205–213, 2003.
E. C. Celik, B. Erhan, B. Gunduz, and E. Lakse, "The effect of low-frequency TENS in the treatment of neuropathic pain in patients with spinal cord injury," Spinal Cord, vol. 51, no. 4, pp. 334–337, 2013.
T. N. Bryce et al., "International spinal cord injury pain classification: part I. Background and description," Spinal Cord, vol. 50, no. 6, pp. 413–417, 2012.
G. S. Miranpuri et al., "Role of microglia and astrocytes in spinal cord injury induced neuropathic pain," Annals of Neurosciences, vol. 28, no. 3–4, pp. 219–228, 2021.
C. Norrbrink, "Transcutaneous electrical nerve stimulation for treatment of spinal cord injury neuropathic pain," Journal of Rehabilitation Research and Development, vol. 46, no. 1–5, pp. 85–94, 2009.
K. A. Sluka, T. L. Lisi, and K. N. Westlund, "Increased release of serotonin in the spinal cord during low, but not high, frequency transcutaneous electric nerve stimulation in rats with joint inflammation," Archives of Physical Medicine and Rehabilitation, vol. 87, no. 8, pp. 1137–1140, 2006.
M. J. Millan, "Descending control of pain," Progress in Neurobiology, vol. 66, no. 6, pp. 355–474, 2002.
P. M. Hingne and K. A. Sluka, "Blockade of NMDA receptors prevents analgesic tolerance to repeated transcutaneous electrical nerve stimulation (TENS) in rats," The Journal of Pain, vol. 9, no. 3, pp. 217–225, 2008.
J. M. DeSantana, V. J. Santana-Filho, and K. A. Sluka, "Modulation between high-and low-frequency transcutaneous electric nerve stimulation delays the development of analgesic tolerance in arthritic rats," Archives of Physical Medicine and Rehabilitation, vol. 89, no. 4, pp. 754–760, 2008.
Y. S. Gwak, C. E. Hulsebosch, and J. W. Leem, "Neuronal‐glial interactions maintain chronic neuropathic pain after spinal cord injury," Neural Plasticity, vol. 2017, no. 1, p. 2480689, 2017.
N. B. Finnerup, "Neuropathic pain and spasticity: intricate consequences of spinal cord injury," Spinal Cord, vol. 55, no. 12, pp. 1046–1050, 2017.
S. Mehta et al., "Neuropathic pain post spinal cord injury part 1: systematic review of physical and behavioral treatment," Topics in Spinal Cord Injury Rehabilitation, vol. 19, no. 1, pp. 61–77, 2013.
B. Rakel et al., "A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment," The Journal of Pain, vol. 11, no. 3, pp. 230–238, 2010.
M. Heutink et al., "Long-term outcomes of a multidisciplinary cognitive behavioural programme for coping with chronic neuropathic spinal cord injury pain," Journal of Rehabilitation Medicine, vol. 46, no. 6, pp. 540–545, 2014.
E. Loh et al., "The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update," Spinal Cord, vol. 60, no. 6, pp. 548–566, 2022.
M. I. Johnson, C. A. Paley, G. Jones, M. R. Mulvey, and P. G. Wittkopf, "Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study)," BMJ Open, vol. 12, no. 2, p. e051073, 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Haoyue Chen, Dae-Keun Jeong (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
